Literature DB >> 20190753

Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization.

Andrew R Cullinane1, Anna Straatman-Iwanowska, Andreas Zaucker, Yoshiyuki Wakabayashi, Christopher K Bruce, Guanmei Luo, Fatimah Rahman, Figen Gürakan, Eda Utine, Tanju B Ozkan, Jonas Denecke, Jurica Vukovic, Maja Di Rocco, Hanna Mandel, Hakan Cangul, Randolph P Matthews, Steve G Thomas, Joshua Z Rappoport, Irwin M Arias, Hartwig Wolburg, A S Knisely, Deirdre A Kelly, Ferenc Müller, Eamonn R Maher, Paul Gissen.   

Abstract

Arthrogryposis, renal dysfunction and cholestasis syndrome (ARC) is a multisystem disorder associated with abnormalities in polarized liver and kidney cells. Mutations in VPS33B account for most cases of ARC. We identified mutations in VIPAR (also called C14ORF133) in individuals with ARC without VPS33B defects. We show that VIPAR forms a functional complex with VPS33B that interacts with RAB11A. Knockdown of vipar in zebrafish resulted in biliary excretion and E-cadherin defects similar to those in individuals with ARC. Vipar- and Vps33b-deficient mouse inner medullary collecting duct (mIMDC-3) cells expressed membrane proteins abnormally and had structural and functional tight junction defects. Abnormal Ceacam5 expression was due to mis-sorting toward lysosomal degradation, but reduced E-cadherin levels were associated with transcriptional downregulation. The VPS33B-VIPAR complex thus has diverse functions in the pathways regulating apical-basolateral polarity in the liver and kidney.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190753      PMCID: PMC5308204          DOI: 10.1038/ng.538

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  78 in total

1.  Rab7 prevents growth factor-independent survival by inhibiting cell-autonomous nutrient transporter expression.

Authors:  Aimee L Edinger; Ryan M Cinalli; Craig B Thompson
Journal:  Dev Cell       Date:  2003-10       Impact factor: 12.270

2.  Immunomodulatory roles of the carcinoembryonic antigen family of glycoproteins.

Authors:  Ling Shao; Matthieu Allez; Mee-Sook Park; Lloyd Mayer
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

3.  High-resolution in situ hybridization to whole-mount zebrafish embryos.

Authors:  Christine Thisse; Bernard Thisse
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

4.  Identification of regions required for apical membrane localization of human multidrug resistance protein 2.

Authors:  Paul E Bandler; Christopher J Westlake; Caroline E Grant; Susan P C Cole; Roger G Deeley
Journal:  Mol Pharmacol       Date:  2008-04-01       Impact factor: 4.436

5.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

6.  Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis.

Authors:  M C Wapenaar; A J Monsuur; A A van Bodegraven; R K Weersma; M R Bevova; R K Linskens; P Howdle; G Holmes; C J Mulder; G Dijkstra; D A van Heel; C Wijmenga
Journal:  Gut       Date:  2007-11-07       Impact factor: 23.059

7.  VPS33B mutation with ichthyosis, cholestasis, and renal dysfunction but without arthrogryposis: incomplete ARC syndrome phenotype.

Authors:  Laura N Bull; Venus Mahmoodi; Alastair J Baker; Rosamond Jones; Sandra S Strautnieks; Richard J Thompson; A S Knisely
Journal:  J Pediatr       Date:  2006-02       Impact factor: 4.406

8.  Rab11-FIP2 regulates differentiable steps in transcytosis.

Authors:  Nicole A Ducharme; Janice A Williams; Asli Oztan; Gerard Apodaca; Lynne A Lapierre; James R Goldenring
Journal:  Am J Physiol Cell Physiol       Date:  2007-07-11       Impact factor: 4.249

9.  MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity.

Authors:  Thomas Müller; Michael W Hess; Natalia Schiefermeier; Kristian Pfaller; Hannes L Ebner; Peter Heinz-Erian; Hannes Ponstingl; Joachim Partsch; Barbara Röllinghoff; Henrik Köhler; Thomas Berger; Henning Lenhartz; Barbara Schlenck; Roderick J Houwen; Christopher J Taylor; Heinz Zoller; Silvia Lechner; Olivier Goulet; Gerd Utermann; Frank M Ruemmele; Lukas A Huber; Andreas R Janecke
Journal:  Nat Genet       Date:  2008-08-24       Impact factor: 38.330

10.  Drosophila HOPS and AP-3 complex genes are required for a Deltex-regulated activation of notch in the endosomal trafficking pathway.

Authors:  Marian Wilkin; Pajaree Tongngok; Nicole Gensch; Sylvaine Clemence; Masato Motoki; Kenta Yamada; Kazuya Hori; Maiko Taniguchi-Kanai; Emily Franklin; Kenji Matsuno; Martin Baron
Journal:  Dev Cell       Date:  2008-11       Impact factor: 12.270

View more
  56 in total

Review 1.  Tubular transport: core curriculum 2010.

Authors:  Marta Christov; Seth L Alper
Journal:  Am J Kidney Dis       Date:  2010-10-30       Impact factor: 8.860

Review 2.  Zebrafish models of human liver development and disease.

Authors:  Benjamin J Wilkins; Michael Pack
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

3.  Structural basis of Vps33A recruitment to the human HOPS complex by Vps16.

Authors:  Stephen C Graham; Lena Wartosch; Sally R Gray; Edward J Scourfield; Janet E Deane; J Paul Luzio; David J Owen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

4.  On the endosomal function and gene nomenclature of human SPE-39.

Authors:  Steven W L'Hernault; Victor Faundez
Journal:  Nat Genet       Date:  2011-03       Impact factor: 38.330

5.  hVps41 and VAMP7 function in direct TGN to late endosome transport of lysosomal membrane proteins.

Authors:  Maaike S Pols; Eline van Meel; Viola Oorschot; Corlinda ten Brink; Minoru Fukuda; M G Swetha; Satyajit Mayor; Judith Klumperman
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.

Authors:  Yavuz Bayram; Ender Karaca; Zeynep Coban Akdemir; Elif Ozdamar Yilmaz; Gulsen Akay Tayfun; Hatip Aydin; Deniz Torun; Sevcan Tug Bozdogan; Alper Gezdirici; Sedat Isikay; Mehmed M Atik; Tomasz Gambin; Tamar Harel; Ayman W El-Hattab; Wu-Lin Charng; Davut Pehlivan; Shalini N Jhangiani; Donna M Muzny; Ali Karaman; Tamer Celik; Ozge Ozalp Yuregir; Timur Yildirim; Ilhan A Bayhan; Eric Boerwinkle; Richard A Gibbs; Nursel Elcioglu; Beyhan Tuysuz; James R Lupski
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

7.  Mutations in Subunits of the Activating Signal Cointegrator 1 Complex Are Associated with Prenatal Spinal Muscular Atrophy and Congenital Bone Fractures.

Authors:  Ellen Knierim; Hiromi Hirata; Nicole I Wolf; Susanne Morales-Gonzalez; Gudrun Schottmann; Yu Tanaka; Sabine Rudnik-Schöneborn; Mickael Orgeur; Klaus Zerres; Stefanie Vogt; Anne van Riesen; Esther Gill; Franziska Seifert; Angelika Zwirner; Janbernd Kirschner; Hans Hilmar Goebel; Christoph Hübner; Sigmar Stricker; David Meierhofer; Werner Stenzel; Markus Schuelke
Journal:  Am J Hum Genet       Date:  2016-02-25       Impact factor: 11.025

Review 8.  The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases.

Authors:  Shanna L Bowman; Jing Bi-Karchin; Linh Le; Michael S Marks
Journal:  Traffic       Date:  2019-06       Impact factor: 6.215

9.  ARC Syndrome-Linked Vps33B Protein Is Required for Inflammatory Endosomal Maturation and Signal Termination.

Authors:  Mohammed Ali Akbar; Rajakumar Mandraju; Charles Tracy; Wei Hu; Chandrashekhar Pasare; Helmut Krämer
Journal:  Immunity       Date:  2016-08-02       Impact factor: 31.745

Review 10.  Function and regulation of the endosomal fusion and fission machineries.

Authors:  Alexis Gautreau; Ksenia Oguievetskaia; Christian Ungermann
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-03-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.